Aortic Stenosis Forecast In 25 Major Markets 2018-2028

Dublin, Aug. 21, 2018 (GLOBE NEWSWIRE) -- The "Aortic Stenosis Forecast In 25 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Aortic Stenosis (AS) is the occlusion or loss of aortic valve surface area resulting in stenosis of the aortic valve. Currently, AS is thought to be the most common form of valvular heart disease in Western countries.

This report provides the current prevalent population for AS across 25 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Norway, Sweden, Denmark, Finland, Iceland, Ireland, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report provides an overview of the risk factors, aetiology, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team , several of the main symptoms and co-morbidities of AS have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for AS include:

• Previous myocardial infarct / Angina
• Carotid atherosclerosis
• COPD
• Lower limb atherosclerosis
• Atrial fibrillation
• Heart failure
  

Reasons to buy

• Ability to quantify patient populations in global AS market to target the development of future products, pricing strategies and launch plans.
• Further insight into the prevalence of the subdivided types of AS and identification of patient segments with high potential.
• Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
• Better understanding on the impact of specific co-morbid conditions on the prevalent population of AS patients.
• Identification of AS patient sub-populations that require treatment.
• Better understanding of the specific markets that have the largest number of AS patients.

Key Topics Covered

1. List Of Tables And Figures
2. Introduction
3. Cause Of The Disease
4. Risk Factors & Prevention
5. Diagnosis Of The Disease
6. Variation By Geography/Ethnicity
7. Disease Prognosis & Clinical Course
8. Management Of Aortic Valve Stenosis
9. Key Comorbid Conditions / Features Associated With The Disease
10. Methodology For Quantification Of Patient Numbers
11. Additional Data
12. Top-Line Prevalence For Aortic Stenosis
13. Features Of Aortic Stenosis Patients
14. Mild Aortic Stenosis
15. Moderate Aortic Stenosis
16. Severe Aortic Stenosis
17. Symptomatic
18. Asymptomatic
19. Comorbidities Of Aortic Stenosis Patients
20. Moderate Aortic Stenosis
21. Severe Aortic Stenosis
22. Symptomatic
23. Asymptomatic
24. Abbreviations Used In The Report
25. Other Publisher Services & Solutions
26. Reports & Publications
27. Online Epidemiology Databases
28. Online Pharmaceutical Pricing Database
29. References
30. Appendix
    

For more information about this report visit https://www.researchandmarkets.com/research/wh66v8/aortic_stenosis?w=12

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Cardiovascular Drugs